TNF Pharmaceuticals Statistics
Total Valuation
TNFA has a market cap or net worth of $4.01 million. The enterprise value is -$8.61 million.
Market Cap | 4.01M |
Enterprise Value | -8.61M |
Important Dates
The last earnings date was Monday, August 19, 2024, before market open.
Earnings Date | Aug 19, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
TNFA has 2.37 million shares outstanding. The number of shares has increased by 44.02% in one year.
Shares Outstanding | 2.37M |
Shares Change (YoY) | +44.02% |
Shares Change (QoQ) | +6.28% |
Owned by Insiders (%) | 8.36% |
Owned by Institutions (%) | 3.25% |
Float | 2.17M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.48, with a Debt / Equity ratio of 0.07.
Current Ratio | 2.48 |
Quick Ratio | 2.26 |
Debt / Equity | 0.07 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -297.63% and return on invested capital (ROIC) is -139.31%.
Return on Equity (ROE) | -297.63% |
Return on Assets (ROA) | -32.43% |
Return on Capital (ROIC) | -139.31% |
Revenue Per Employee | n/a |
Profits Per Employee | -$3.89M |
Employee Count | 6 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.28% in the last 52 weeks. The beta is 2.70, so TNFA's price volatility has been higher than the market average.
Beta (5Y) | 2.70 |
52-Week Price Change | -94.28% |
50-Day Moving Average | 1.85 |
200-Day Moving Average | 3.71 |
Relative Strength Index (RSI) | 40.95 |
Average Volume (20 Days) | 60,437 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -13.40M |
Pretax Income | -12.29M |
Net Income | -23.35M |
EBITDA | n/a |
EBIT | -13.40M |
Earnings Per Share (EPS) | -$11.94 |
Balance Sheet
The company has $13.07 million in cash and $25,803 in debt, giving a net cash position of $13.04 million or $5.50 per share.
Cash & Cash Equivalents | 13.07M |
Total Debt | 25,803 |
Net Cash | 13.04M |
Net Cash Per Share | $5.50 |
Equity (Book Value) | 382,293 |
Book Value Per Share | -0.02 |
Working Capital | 8.57M |
Cash Flow
Operating Cash Flow | -9.67M |
Capital Expenditures | n/a |
Free Cash Flow | -9.67M |
FCF Per Share | -$4.08 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
TNFA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -44.02% |
Shareholder Yield | -44.02% |
Earnings Yield | -582.91% |
FCF Yield | -241.38% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on February 15, 2024. It was a reverse split with a ratio of 0.0333333:1.
Last Split Date | Feb 15, 2024 |
Split Type | Reverse |
Split Ratio | 0.0333333:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |